Introduction
All living cells appear to be capable of exiting the normal cell cycle and entering a reversible state termed quiescence or G-zero (G 0 ), which is typically characterized by low metabolic activity, including low rates of protein synthesis and transcription. Initiation of the G 0 program is a highly coordinated process, which requires downregulation of conserved nutrient-, growth factor-and/or hormoneresponsive signal transduction pathways. In the yeast Saccharomyces cerevisiae, downregulation of the nutrient-regulated kinase activities of the conserved Target Of Rapamycin Complex 1 (TORC1), or the protein kinase A (PKA) had been found to drive cells into a G 0 -like state and to significantly extend chronological life span (CLS). [1] [2] [3] [4] In contrast, loss of the kinase activity of Rim15 prevents access to G 0 and decreases CLS. [5] [6] [7] TORC1 (via its substrate Sch9) and PKA are thought to signal in parallel pathways to positively regulate ribosome biogenesis and growth and, by maintaining Rim15 in an inactive state in the cytoplasm, to negatively regulate entry into G 0 . [8] [9] [10] [11] [12] The molecular mechanisms linking Rim15 to distal readouts such as the expression of specific nutrient-regulated genes (e.g., HSP26; see below), trehalose and glycogen accumulation, and CLS extension involve the stress-response and post-diauxic shift transcription factors Msn2/4 and Gis1, 7, 13, 14 respectively, as well as the recently identified paralogous Rim15 target proteins Igo1 and Igo2. 15 Intriguingly, during initiation of the G 0 program, phosphorylation by Rim15 stimulates Igo proteins to associate with both Lsm12, which likely binds to the 3' untranslated region (UTR) of mRNAs in a complex with Pbp1 and Pbp4, 16, 17 as well as with the decapping activator Dhh1. This latter event appears to be key for newly expressed mRNAs to be both sheltered from degradation via the 5'-3' mRNA decay pathway and channeled towards stress granules (SGs) for strain Y7092; C. Boone lab collection), harboring the HSP26-yEmRFP reporter plasmid, with the Euroscarf collection of 4,857 viable gene deletion mutants essentially as described earlier. 19 The resulting triple mutant collection was screened for mutants that, unlike igo1Δ igo2Δ cells, were able to express HSP26-yEmRFP and consequently form purple colonies. Notably, since Rim15 controls both activation of transcription (via a still partially understood mechanism that implicates the transcription factors Msn2/4 and Gis1) and posttranscriptional stabilization of mRNAs (by a process that implicates Igo1/2) (Fig. 1) , we reasoned that candidate mutations that expresses, under the control of the yeast HSP26 promoter, a new yeast enhanced variant of the mCherry monomeric red f luorescent protein (yEmRFP), 18 which confers a vivid purple color to wild-type cells during and following initiation of the G 0 program. As expected, only wild-type cells containing the HSP26-yEmRFP reporter plasmid (pXL029), but not corresponding rim15Δ or igo1Δ igo2Δ cells, were able to form purple colonies when grown for five days on plates containing synthetic defined (SD) medium ( Fig. 2A) . Next, we crossed an igo1Δ igo2Δ strain (XL111; MATα, igo1Δ::NatMX4, igo2Δ::HphMX4, can1Δ::STE2pr-His5, lyp1Δ, ura3Δ, his3Δ1; derived from subsequent translation (Fig. 1) . Given the conserved nature of Igo proteins, 15 these findings indicate that stabilization of specific mRNAs is a critical determinant of cell differentiation and CLS.
The mRNA Decapping Pathway Targets HSP26 mRNAs in the Absence of Igo1 and Igo2
To further define the molecular function of Igo1/2, we performed a genomewide screen for mutations that suppress the defect of igo1Δ igo2Δ cells in HSP26 expression during initiation of the G 0 program. To this end, we constructed an HSP26-yEmRFP reporter gene that by the cyclin-cyclin-dependent kinase complex Pho80-Pho85) 8, 10 mediates tandem 14-3-3 binding to guarantee optimal sequestration of Rim15 in the cytoplasm, where it is kept inactive through additional PKA-mediated phosphorylation events.
5,9 toRC1 inactivation (e.g., following treatment of cells with rapamycin or following nutrient starvation) causes initiation of the G 0 program in part by abrogating the cytoplasmic retention of Rim15. Nuclear Rim15, presumably released from PKA-mediated inhibition, 26 has a dual role in controlling gene expression by activating transcription of Msn2/4-and Gis1-dependent genes (1) and protecting the corresponding transcripts from degradation via an igo1/2-dependent mechanism (2-7). [13] [14] [15] Accordingly, Rim15-dependent phosphorylation of Ser 64 in igo1 and Ser 63 in igo2 (both of which likely shuttle between the cytoplasm and the nucleus) leads to the formation of specific messenger ribonucleoprotein (mRNP) complexes (possibly already in the nucleus as depicted or, alternatively, in the cytoplasm) that contain at least igo1/2, Lsm12, the poly(A)-binding protein Pab1 interactor Pbp1, and Pbp4, as well as a nutrient-regulated mRNA (e.g., HSP26) that needs to be translated as part of the quiescence program (2) . to this end, the cytoplasmic mRNP complexes likely associate with translation initiation factors and ribosomes for direct translation (3). Alternatively, they may transiently assemble (to some extent in PBs) with 5'-3' degradation factors (4) . Notably, Dhh1 may either be incorporated into HSP26 mRNA-containing mRNPs while they reside in the nucleus, or-as depicted in our model-join the corresponding mRNPs in the cytoplasm (e.g., during or following their unloading from ribosomes and disassembly of translation initiation factors) (5) . the interaction of p-Ser 64 -igo1 with Dhh1 presumably prevents decapping and subsequent 5'-3' degradation of the associated mRNA and promotes both disassembly of 5'-3' degradation factors from the mRNP (6) and reassembly of translation initiation factors (7), a process that may specifically occur in stress granules (SGs). Such mRNP complexes (that may still contain igo1/2) are thought to exit SGs and to subsequently associate with ribosomes for translation of the corresponding mRNA (8) . in the absence of functional igo1/2, mRNAs such as the HSP26 mRNA remain unguarded from Dcp1/2-and Xrn1-mediated decapping and 5'-3' decay (9), respectively, and are therefore prone to degradation. mRNAs, which then failed to be translated into proteins. 15 mRNA decapping is thought to occur in multiple, sequential steps, which include the partial deadenylation of the poly(A) tail by the NOT-Ccr4 complex, recruitment to the corresponding oligoadenylated mRNAs of the Lsm-Pat1 complex-which, as recently shown in metazoans, serves as a scaffold that binds (via Pat1b) both deadenylation and decapping enzymes 22, 23 -and Dhh1-mediated activation of decapping following remodeling of the 5' structure of the mRNA. 20, 24 Since a defect in any of these steps in the mRNA decapping process can suppress the phenotype of igo1Δ igo2Δ cells in HSP26 mRNA (and Hsp26 protein) expression and given the finding that Igo proteins (following phosphorylation by Rim15) interact with Dhh1, 15 Igo proteins are likely to inhibit mRNA decapping at a stage from which mRNAs can still successfully be retrieved for translation (following disassembly of 5'-3' decay factors and assembly of translation initiation factors that may possibly occur within stress granules) (Fig. 1) .
To assess further whether loss of LsmPat1 function can also suppress the defect of igo1Δ igo2Δ cells in HSP26 expression following TORC1 inactivation, we next measured HSP26 mRNA and Hsp26 protein levels in rapamycin-treated wildtype, rim15Δ, igo1Δ igo2Δ, pat1Δ, pat1Δ rim15Δ and pat1Δ igo1Δ igo2Δ cells. As expected, loss of Pat1 fully suppressed the defect of igo1Δ igo2Δ cells, but not that of rim15Δ cells, in rapamycininduced HSP26 expression (both at the mRNA and protein levels; Fig. 2B and  C) . These results further support the idea that Rim15 likely has a dual role in controlling gene expression by (1) activating transcription ( Fig. 1) and (2) protecting the corresponding transcripts from degradation via an Igo1/2-dependent mechanism that specifically antagonizes the process of mRNA decapping activation.
In line with such a model, we previously found that loss of the 5'-3' exonuclease Xrn1, which causes processing bodies (PBs) to increase in number and size due to the entrapping of non-degraded mRNAs, 20 allowed igo1Δ igo2Δ cells, but not rim15Δ cells, to accumulate HSP26 suppress the HSP26-yEmRFP expression defect in both rim15Δ and igo1Δ igo2Δ cells are very likely to play a role in regulating transcription rather than mRNA stability. To more specifically focus on the role of Igo proteins in posttranscriptional mRNA stability control, such mutations were eliminated in a secondary screen following which we retained a total of five gene deletions that were able to suppress the defect of igo1Δ igo2Δ cells, but not that of rim15Δ cells. In line with and confirming our previous results, 15 our screen identified the ccr4Δ and dhh1Δ mutations, both of which prevent mRNA decay at early steps of the 5'-3' mRNA decay pathway, 20 as igo1Δ igo2Δ suppressor mutations ( Fig. 2A) . Interestingly, all three additional, newly identified suppressor mutations (i.e., lsm1Δ, lsm6Δ and pat1Δ) affect genes whose products are constituents of the Lsm1-7/Pat1 (Lsm-Pat1) complex that activates mRNA decapping following deadenylation. 21 Notably, the other subunits of this complex are either essential (Lsm2-5), or their absence did not significantly suppress (Lsm7) the igo1Δ igo2Δ phenotype in our assays (data not shown). stabilizing the growth-associated protein-43 (GAP-43) mRNA in response to nerve growth factor treatment. 25 Thus, an exciting challenge will be to test whether the homologs of Igo proteins in higher eukaryotes may have an evolutionarily conserved role in mRNA stability control, which-as observed in yeast-may be critical for cell differentiation and life span.
Consistent with this view, Igo proteins appear to reach SGs following a transient stopover in PBs in glucose-limited cells. 15 
Outlook
While our studies have pinpointed a role for Igo proteins in stabilization of nutrient-regulated mRNAs, which appears to be critical for both initiation of the G 0 program and proper setup of CLS, 15 they also rise a number of interesting issues to be tackled in the future. For instance, rapamycin-induced expression of the HSP26-LacZ and HSP26-yEmRFP reporter genes, like expression of HSP26, was strongly dependent on Igo1/2, indicating that either the promoter region or the 5' UTR of HSP26 critically defines the fate of the corresponding mRNA by a process that implicates Igo1/2. One attractive model, to be tested in this context, is that Rim15 may be recruited to specific promoter regions to coordinate both temporal and spatial activation of Igo1/2 and ensure timely co-transcriptional loading of activated Igo1/2 onto Lsm12-, Pbp1-and Pbp4-containing messenger ribonucleoprotein (mRNP) complexes. An alternative model that can be experimentally addressed is that activated Igo1/2 may be able to (directly or indirectly) bind to a specific structure or sequence motif within the 5' UTR of nutrient-regulated mRNAs such as the HSP26 mRNA. Moreover, our present findings suggest that Igo1/2 inhibit 5'-3' mRNA decay of mRNAs by interfering with the mRNA decapping activation system. Future studies that specifically focus on structural/functional aspects of the interaction between Igo1/2 and Dhh1 (and possibly the Lsm-Pat1 complex) are therefore very likely to significantly enhance our general understanding of the mechanisms that control mRNA decay. Finally, the closest homolog of Igo1/2 in mammals, i.e., ARPP-19, has previously been suggested to control axon growth and synaptic plasticity specifically by
